Recruiting

NCT Number: NCT00899405

Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of California Davis Cancer Center

Sacramento, California, 95817, United States

Location status: Recruiting

Location contact

Office of Clinical Research

CONTACT

[email protected]

916-382-6970

About this study

OBJECTIVES:

Examine the mutational status of the EGFR pathway in tumor and blood samples from patients with lung cancer.
Correlate the EGFR pathway mutations in these samples with clinical outcomes of these patients.

OUTLINE: Archived tumor tissue and blood samples are analyzed via PCR to detect EGFR pathway mutations in DNA.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

DISEASE CHARACTERISTICS:

Histologically or cytologically confirmed lung cancer

PATIENT CHARACTERISTICS:

Not specified

PRIOR CONCURRENT THERAPY:

May have received prior EGFR inhibitors

Treatment and study plan

Primary outcomes

Mutational status of the EGFR pathway

Time frame: up to 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Office of Clinical Research

CONTACT

[email protected]

916-382-6970

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Official study title

EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood

Important dates

Study start: 2004
Primary completion: 2034
Study completion: 2034
First posted: May 12, 2009
Registry last updated: Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting